<DOC>
	<DOCNO>NCT02942680</DOCNO>
	<brief_summary>evaluate safety preoperative aspirin therapy perform bypass surgery condition artificial blood circulation</brief_summary>
	<brief_title>Efficacy Safety Aspirin Therapy With CABG</brief_title>
	<detailed_description>The hypothesis study aspirin therapy start 24 hour CABG safe . The effectiveness hypothesis assess presence 30-day period CABG myocardial infarction , ischemic stroke , repeat revascularizations</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients 18 year age old Patient able give inform consent Missing consent Urgent emergent surgery Offpump CABG Ð atient clear indication anticoagulation ( eg . mechanical heart valve , atrial fibrillation ) ADP receptor antagonist ( eg . drugeluting stent ) History bleed diathesis , significant GI bleed , ICH , liver failure Allergy intolerance aspirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>coronary artery bypass grafting</keyword>
</DOC>